Concussion

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium

Staff June 10, 2025

SARASOTA, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for...

PreveCeutical Welcomes Dr. Deepak Sampath, PhD. as Corporate Advisor

Staff June 2, 2025

Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"),...

PreveCeutical Welcomes Stephen Glover as Corporate Advisor

Staff May 26, 2025

Vancouver, British Columbia--(Newsfile Corp. - May 26, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the...

PreveCeutical Closes Final Tranche of Up-Sized Non-Brokered Private Placement

Staff May 22, 2025

Vancouver, British Columbia--(Newsfile Corp. - May 22, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),...

PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies

Staff May 14, 2025

Vancouver, British Columbia--(Newsfile Corp. - May 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), a...

Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia

Staff May 13, 2025

SARASOTA, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel...

PreveCeutical Closes Initial Tranche of Up-Sized Non-Brokered Private Placement

Staff April 28, 2025

Vancouver, British Columbia--(Newsfile Corp. - April 28, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),...

Oragenics, Inc. to Participate at the 15th Annual Traumatic Brain Injury Conference

Staff April 23, 2025

SARASOTA, Fla., April 23, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing novel intranasal therapies...

PreveCeutical Announces Up-Sized Non-Brokered Private Placement

Staff April 14, 2025

Vancouver, British Columbia--(Newsfile Corp. - April 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company"...

Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial

Staff April 9, 2025

SARASOTA, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel...

Rapid Dose Therapeutics Provides Update on the Clinical Trial Development and the Commitment to NFL Funded Cannabinoid Research

Staff April 8, 2025

Burlington, Ontario--(Newsfile Corp. - April 8, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotech...

PreveCeutical Announces Update to Non-Brokered Private Placement

Staff April 2, 2025

Vancouver, British Columbia--(Newsfile Corp. - April 2, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company"...

Experience Onward Partners with Enthea to Expand Access to Psilocybin Treatment Through a Medical Tourism Benefit

Staff April 2, 2025

Portland, Oregon--(Newsfile Corp. - April 2, 2025) - Experience Onward, Oregon's premier state-licensed psilocybin service center, is proud to announce...

Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress

Staff March 27, 2025

ONP-002 Advances Toward Phase IIa Concussion Trial with Strengthened Financial Foundation and Industry MomentumSARASOTA, Fla., March 27, 2025 (GLOBE NEWSWIRE)...

AI is here. NSU forum explores how it will change business, healthcare and everything else

Staff March 21, 2025

NATCHITOCHES, La., March 21, 2025 /PRNewswire/ -- "AI works 120 million times faster than the human brain," according to Dr....

New Psilocybin Service Center Opens to Support Athletes, Veterans, and Others with Traumatic Brain Injuries

Staff March 19, 2025

Founded by Former NHL Player and mental health advocate Daniel Carcillo, the Portland center is the first of its kind...

PreveCeutical Announces Update to Private Placement

Staff March 10, 2025

Vancouver, British Columbia--(Newsfile Corp. - March 10, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company"...

Header Restriction Policy in Youth Soccer Shows Promising Impact on Concussion Rates

Staff March 10, 2025

SAN DIEGO, March 10, 2025 /PRNewswire/ -- A new study presented at the 2025 Annual Meeting of the American Academy...

Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

Staff March 6, 2025

A growing body of clinical evidence supports the use of Firefly's FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment...

Sway Medical, Inc. Announces FDA 510(k) Clearance of its Comprehensive Concussion Management System

Staff February 26, 2025

TULSA, Okla., Feb. 26, 2025 /PRNewswire/ -- Sway Medical, Inc., the company that created the Mobile Concussion Management category, is...